Market Crash: 4 buying opportunities for value investors

High quality stocks like Ramsay Health Care Limited (ASX:RHC), Corporate Travel Management Ltd (ASX:CTD) and InvoCare Limited (ASX:IVC) have dropped sharply since the start of 2016.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It's never enjoyable to see the value of your investments fall especially when markets are so volatile and the only certainty is uncertainty.

The recent market sell-off will also be confusing to many investors who would have expected the sharemarket to be rising on the back of record-low interest rates.

Investors are now asking "Weren't dividend stocks supposed to go up considering interest rates are down?".

Instead, investors are seeing the traditional dividend stocks like the banks getting absolutely hammered. Australia and New Zealand Banking Group (ASX: ANZ) has been the worst hit with its share price falling by more than 38% since reaching its 52-week high of $37.25 back in March 2015. Although there is a good possibility of its dividend being cut, it is now trading on a historical fully franked dividend yield of 7.9%. That's a whopping 11.3% grossed up!

The dilemma investors now face is whether or not share prices have further to fall or whether or not the worst is over.

Believe it or not, there is a silver lining to the recent plunge in markets – shares that you thought were overpriced just a few months ago, are probably now significantly cheaper and are now much better value propositions. While some businesses, such as fund managers, will be directly affected by recent moves in the markets, many will be unaffected and for them, it will be business as usual.

With that in mind, here are four stocks that have been heavily sold off in recent weeks that look far more attractive now:

1. Ramsay Health Care Limited (ASX: RHC) shares have dropped nearly 17% since the start of 2016 and are now trading at $56.90. The private hospital operator is facing some pressure domestically from health insurers but is rapidly expanding its footprint in overseas markets. Along with further acquisitions in France, Ramsay is also now looking to enter the Chinese market which is rapidly increasing its spending on healthcare. Investors should expect Ramsay to deliver Core NPAT and Core EPS growth of 12%-14% for FY16.

2. Corporate Travel Management Ltd (ASX: CTD) shares reached a high of $13.67 last December following the announcement it was acquiring a Californian based travel company for $47.6 million. The company also upgraded its earnings guidance at the same time thanks to strong trading conditions and the additional contribution from the new acquisition. Since then, the share price has fallen nearly 18% and is now approaching value territory in my opinion.

3. InvoCare Limited (ASX: IVC) shares are being punished today and are now trading close to their 52-week low of $10.69. The funeral and cemetery operator is generally viewed as a highly defensive and predictable stock but its recent expansion into the US market has seen this reputation come under pressure. Larger than expected losses in this market have weighed on InvoCare's share price despite continued growth in the domestic market. Although there could be further short-term pain to come, the long-term demographic fundamentals should support a higher share price in the future and investors should watch this stock closely.

4. Tassal Group Limited (ASX: TGR) shares have lost nearly 17% of their value in the space of eight trading sessions and are now trading at $4.24 per share and a price to earnings ratio of less than 13. This appears quite attractive as the regulatory inquiry in relation to aquaculture has concluded, new supply agreements with major supermarkets are in place and the benefits from its acquisition of De Costi seafood are yet to be realised. Add to this growing demand for healthier food options like salmon and seafood and the growth outlook for Tassal is promising. Investors will also benefit from a growing dividend which is expected to yield around 3.8% in FY16.

Motley Fool contributor Christopher Georges owns shares in Ramsay Health Care. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »